← Leaderboards
Brendan McAdam
Vanderbilt University
$241,835
Attributed
$241,835
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$241,835 · 4
By mechanism
M01$241,835 · 4
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Nancy Joan Brown$32,445,188
- Agnes B Fogo$7,762,267
- Matthew Douglas Breyer$9,196,649
- Raymond Nelson Dubois$22,706,669
- Douglas Eugene Vaughan$19,799,621
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchCyclooxygenase InhibitorsProstacyclinsAspirinDrug Screening /EvaluationEndotoxinsHypoglycemic AgentsInflammationPharmacokineticsPharmacologyPostmenopauseProstaglandin EProstaglandinsRenin Angiotensin SystemAcetaminophenThiazolesAngiotensin IiAngiotensin /Renin /Aldosterone HypertensionAntipyretic
Grant awards (7)
THE EFFECTS OF SELECTIVE INHIBITION OF COX-2 WITH ROFECOXIB ON PROSTAGLANDIN$17,039
M01 · FY2005 · RR
CLINICAL PHARMACOLOGY OF ACETAMINOPHEN AND ASPIRIN IN HUMAN INFLAMMATION$15,658
M01 · FY2005 · RR
THE EFFECT OF PIOGLITAZONE ON PROSTACYCLIN FORMATION IN HEALTHY VOLUNTEERS AN$13,816
M01 · FY2005 · RR
Clinical Pharmacology of Acetaminophen and Aspirin in Human Inflammation$103,438
M01 · FY2004 · RR
The Effect of Pioglitazone on Prostacyclin Formation in Healthy Volunteers an...$46,217
M01 · FY2004 · RR
The Effects of Selective Inhibition of COX-2 with Rofecoxib on Prostaglandin...$30,812
M01 · FY2004 · RR
The effect of Activation of the Renin-Angiotensin System on Novel Circulating...$14,855
M01 · FY2004 · RR